ArticleCureus2026
Diffuse Myocardial Injury With Diabetes-Related Advanced Glycation End Product Accumulation in Dilated Cardiomyopathy: Pathological Insights From an Autopsy Case.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advances in the application of nanoparticles for the diagnosis and treatment of diabetic cardiomyopathy.Frontiers in cell and developmental biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes mellitus is a systemic metabolic disorder associated with diverse long-term complications, among which cardiovascular involvement is a major cause of morbidity and mortality. A central pathogenic mechanism linking diabetes to tissue injury is the formation and accumulation of advanced glycation end products (AGEs), which exert deleterious effects through receptor-mediated signaling via the receptor for AGEs (RAGE) and receptor-independent collagen cross-linking. However, pathological evidence directly demonstrating the contribution of AGE accumulation to advanced cardiac dysfunction in human autopsy cases remains limited. We report an autopsy case of a Japanese man in his late 60s with long-standing idiopathic dilated cardiomyopathy who subsequently developed diabetes mellitus and progressive heart failure. His clinical course was complicated by secondary pulmonary hypertension, followed by hepatic and renal dysfunction, and ultimately resulted in death due to multiple organ failure. Gross examination revealed marked cardiac enlargement with severe biventricular dilatation without ventricular wall hypertrophy. Histologically, the myocardium showed diffuse interstitial and perimyocytic fibrosis with transmural myocardial atrophy. The pulmonary arteries demonstrated fibrous intimal thickening consistent with secondary pulmonary hypertension. Renal pathology showed arteriolosclerotic nephropathy with superimposed diabetic nephropathy, and the liver exhibited features of congestive hepatopathy. Immunohistochemical analyses demonstrated prominent myocardial deposition of pentosidine, a representative AGE, along with increased expression of the oxidative stress marker 8-hydroxy-2'-deoxyguanosine (8-OHdG) and immunoreactivity for RAGE. These findings suggest that diabetes-associated AGE accumulation and oxidative stress contributed to qualitative alterations of myocardial collagen within pre-existing diffuse fibrosis, potentially accelerating myocardial stiffening and progression of dilated cardiomyopathy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.